Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:31 PM
Ignite Modification Date:
2025-12-24 @ 12:31 PM
NCT ID:
NCT01306461
Eligibility Criteria:
Inclusion Criteria:
* Aged 18 years or more
* A diagnosis of ocular hypertension or open-angle glaucoma
* Meet specific IOP level at visit 1 (screening)and visit 2 (baseline)
* Meet specific visual acuity score
* Are willing to follow instructions
* Have provided a written informed consent
Exclusion Criteria:
* Females who are pregnant, nursing or planning pregnancy
* IOP greater than 36 mmHg at any time point at screening or baseline
* Diagnosis of angle-closure glaucoma or secondary glaucoma other than capsular or pigmentary glaucoma in either eye
* Suspected contraindication or hypersensitivity to study medications tafluprost or timolol (e.g. asthma, low pulse) or to wash-out medication brinzolamide
* Glaucoma filtration surgery or any other ocular surgery (including ocular laser procedures) within 6 months prior to Screening
* Use of contact lenses at Screening or during the study
* Presence of any abnormality or significant illness that could be expected to interfere with the patient safety or study parameters
* Current participation in another clinical trial within the last 30 days
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01306461
Study Brief:
Protocol Section:
NCT01306461